Krystal Biotech, Inc.
KRYSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Krystal Biotech, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 10 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 26, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| FMR LLC | 2026-03-31 | 4,373,987 | $1.13B | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 6,747 | $1.74M | SEC filing |
| HANSEATIC MANAGEMENT SERVICES INC | 2026-03-31 | 2,997 | $774K | SEC filing |
| Cetera Investment Advisers | 2026-03-31 | 6,206 | $1.6M | SEC filing |
| Palisades Investment Partners, LLC | 2026-03-31 | 45,405 | $11.7M | SEC filing |
| YOUSIF CAPITAL MANAGEMENT, LLC | 2026-03-31 | 7,131 | $1.84M | SEC filing |
| AlphaCentric Advisors LLC | 2026-03-31 | 1,918 | $495K | SEC filing |
| AdvisorNet Financial, Inc | 2026-03-31 | 171 | $44.2K | SEC filing |
| Measured Wealth Private Client Group, LLC | 2026-03-31 | 1,826 | $472K | SEC filing |
| Atle Fund Management AB | 2026-03-31 | 37,579 | Not shown | SEC filing |
| DNB Asset Management AS | 2026-03-31 | 3,100 | $801K | SEC filing |
| Walleye Capital LLC | 2026-03-31 | 354 | $91.4K | SEC filing |
| Thrivent Financial for Lutherans | 2026-03-31 | 17,226 | Not shown | SEC filing |
| SEGALL BRYANT & HAMILL, LLC | 2026-03-31 | 79,497 | $20.5M | SEC filing |
| State of Alaska, Department of Revenue | 2026-03-31 | 17,484 | Not shown | SEC filing |
| Ameritas Investment Partners, Inc. | 2026-03-31 | 2,055 | $531K | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 13,520 | $3.49M | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 1,525 | $394K | SEC filing |
| Physician Wealth Advisors, Inc. | 2026-03-31 | 4 | $1.03K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 161 | $41.6K | SEC filing |
- Each value is checked against Krystal Biotech, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Krystal Biotech, Inc.'s share price.
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-25 | Thomas John Charles · EVP, General Counsel | Common Stock | S — Open market or private sale | −1,000 | 347.27 | SEC filing |
| 2026-06-04 | Krishnan Suma · President, R&D | Common Stock | S — Open market or private sale | −2,039 | 310.94 | SEC filing |
| 2026-06-04 | Krishnan Krish S · President and CEO | Common Stock | S — Open market or private sale | −11,461 | 307.68 | SEC filing |
| 2026-06-04 | Krishnan Krish S · President and CEO | Common Stock | S — Open market or private sale | −964 | 311.36 | SEC filing |
| 2026-06-04 | Krishnan Suma · President, R&D | Common Stock | S — Open market or private sale | −400 | 304.89 | SEC filing |
| 2026-06-04 | Krishnan Suma · President, R&D | Common Stock | S — Open market or private sale | −12,729 | 307.81 | SEC filing |
| 2026-06-04 | Krishnan Suma · President, R&D | Common Stock | S — Open market or private sale | −247 | 303.17 | SEC filing |
| 2026-06-04 | Krishnan Suma · President, R&D | Common Stock | S — Open market or private sale | −1,348 | 307.09 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Thomas John Charles · EVP, General Counsel | Common Stock | M — Exercise or conversion of derivative security | +1,000 | SEC filing |
| 2026-06-25 | Thomas John Charles · EVP, General Counsel | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −1,000 | SEC filing |
| 2026-02-27 | Krishnan Krish S · President and CEO | Common Stock | M — Exercise or conversion of derivative security | +5,725 | SEC filing |
| 2026-02-27 | Krishnan Krish S · President and CEO | Restricted Stock Units | M — Exercise or conversion of derivative security | −8,750 | SEC filing |
| 2026-02-27 | Krishnan Suma · President, R&D | Common Stock | M — Exercise or conversion of derivative security | +4,000 | SEC filing |
| 2026-02-27 | ROMANO KATHRYN · Chief Accounting Officer | Common Stock | M — Exercise or conversion of derivative security | +7,500 | SEC filing |
| 2026-02-27 | ROMANO KATHRYN · Chief Accounting Officer | Restricted Stock Units | M — Exercise or conversion of derivative security | −550 | SEC filing |
| 2026-02-27 | Krishnan Krish S · President and CEO | Common Stock | M — Exercise or conversion of derivative security | +22,500 | SEC filing |
Showing 8 of 33 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.